Bristol-Myers Squibb (NY: BMY )
66.98 -0.26 (-0.39%) Official Closing Price Updated: 6:30 PM EDT, Mar 23, 2023 Add to My Watchlist
Press Releases about Bristol-Myers Squibb
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Supplemental Biologics License Application for Breyanzi (lisocabtagene maraleucel) as a Second-Line Therapy for Relapsed or Refractory Large B-cell Lymphoma
February 17, 2022
Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes
February 15, 2022
Tomorrow's Innovators: Kwame Sarpong
December 06, 2021
Via 3BL Media
Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
February 02, 2022
Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials...
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
January 27, 2022
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,...
Topics Death Intellectual Property
Exposures Death Intellectual Property
Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022
December 17, 2021
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
December 21, 2021
Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...
Exposures Product Safety
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
December 10, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 10, 2021 – USA News Group – Researchers led by a scholar from City University of Hong Kong (CityU) have developed a novel...
Topics Artificial Intelligence
Exposures Artificial Intelligence
Encouraging Recruitment of Diverse Talent in the Biopharma Industry
December 02, 2021
Via 3BL Media
Topics Supply Chain
Exposures Supply Chain
Bristol Myers Squibb Announces New PDUFA Date for Mavacamten
November 19, 2021
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following